HealthDay News — Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according to a research letter published online January 8 in JAMA Network ...

Multidisciplinary collaborative approach to care is required for patients with hematological malignancies in pregnancy.

The sNDA is supported by data from the phase 3 ENERGIZE and ENERGIZE-T studies, which evaluated mitapivat vs placebo in patients with NTD and TD alpha- or beta-thalassemia, respectively.

Morning-type pattern significantly linked to lower risks for all-cause and cardiovascular disease-specific mortality compared with non-coffee drinking ...

Meaningful reduction in symptoms seen for some taking an extended course outside of the context of an acute infection ...

Topline data were announced from the AUDACITY trial evaluating the Allurion Gastric Balloon, a swallowable, procedureless intragastric balloon, in adults with obesity.

Posdinemab works by targeting and neutralizing Alzheimer disease-specific phosphorylated tau, preventing its spread to other neurons.

HealthDay News — Doxycycline postexposure prophylaxis (doxyPEP) initiation is associated with decreases in sexually transmitted infections (STIs), according to a study published online January 6 in ...

Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.

Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation.

Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.